What Does Salix Pharmaceuticals Do?

Total employees757
HeadquartersBridgewater
Founded1988

Salix Pharmaceuticals is a specialty pharmaceutical company dedicated to the prevention and treatment of gastrointestinal (GI) diseases. Acquired by Bausch Health Companies Inc. in 2015, Salix operates as a significant business unit, focusing on providing innovative solutions for patients and healthcare professionals in the gastroenterology sector. Their portfolio includes well-known treatments for conditions such as irritable bowel syndrome with diarrhea (IBS-D), hepatic encephalopathy (HE), and opioid-induced constipation (OIC).

Where Is Salix Pharmaceuticals's Headquarters?

HQ Function

Serves as the primary operational hub for Salix Pharmaceuticals within the U.S., overseeing commercial activities, product strategy, medical affairs, and administrative support for its gastroenterology portfolio, under the Bausch Health corporate structure.

Notable Features:

Modern corporate office facilities located within the Somerset Corporate Center, known for its Class A office space, campus amenities, and accessibility.

Work Culture:

As part of Bausch Health, the work culture at the Bridgewater site is focused on innovation in pharmaceuticals, patient-centricity, and achieving performance-driven results. Employees typically experience a dynamic and fast-paced environment with opportunities for professional development within the larger Bausch Health organization.

HQ Significance:

This location is central to Salix's U.S. market leadership in gastroenterology, facilitating the management and distribution of its core products, R&D oversight, and engagement with the healthcare community.

Values Reflected in HQ: The facility and its operations aim to reflect Bausch Health's core values, including a commitment to improving people's lives with its healthcare products, emphasizing scientific rigor, customer focus, and market responsiveness.

Location:

While Salix Pharmaceuticals' primary market focus is the United States, its products are made available in various international markets through Bausch Health's extensive global distribution network. Bausch Health manages the global commercialization, regulatory affairs, supply chain, and market access for Salix's portfolio of GI treatments in numerous countries where they are approved and marketed.

Street Address:

400 Somerset Corporate Blvd

City:

Bridgewater

State/Province:

New Jersey

Country:

USA

Where Else Does Salix Pharmaceuticals Operate Around the World?

Raleigh, North Carolina, USA

Address: 8510 Colonnade Center Dr, Suite 200, Raleigh, NC 27615, USA

Leverages the rich life sciences ecosystem of the Research Triangle Park area, supporting Salix's product development initiatives and commercial activities in the region.

Buying Intent Signals for Salix Pharmaceuticals

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Salix Pharmaceuticals? Meet the Executive Team

As of April 2025, Salix Pharmaceuticals' leadership includes:

Robert Spurr - President, Salix Pharmaceuticals
Thomas J. Appio - Chief Executive Officer, Bausch Health (Parent Company)
John S. Barcay - Senior Vice President, Research & Development, Salix Pharmaceuticals
Yehia Hashad - Executive Vice President of Research and Development and Chief Medical Officer, Bausch Health

Who's Investing in Salix Pharmaceuticals?

Salix Pharmaceuticals has been backed by several prominent investors over the years, including:

Bausch Health Companies Inc. (Parent Company, NYSE/TSX: BHC)
Icahn Capital LP (Major Bausch Health Institutional Investor)
Paulson & Co. Inc. (Major Bausch Health Institutional Investor)
The Vanguard Group, Inc. (Major Bausch Health Institutional Investor)
BlackRock, Inc. (Major Bausch Health Institutional Investor)

What Leadership Changes Has Salix Pharmaceuticals Seen Recently?

Hire1
Exits1

In the last twelve months, the most notable executive change impacting Salix Pharmaceuticals was the appointment of a new Chief Executive Officer for its parent company, Bausch Health. Such leadership transitions at the parent company level are pivotal for the strategic direction and oversight of its subsidiary businesses, including Salix.

Departures

Brent Saunders, Brent Saunders concluded his tenure as Interim CEO of Bausch Health, facilitating a leadership transition to the new permanent CEO. He remains Chairman of the Board.

New Appointments:

Thomas J. Appio, Thomas J. Appio was appointed as the new CEO of Bausch Health. His leadership sets the strategic direction for all its businesses, including Salix Pharmaceuticals.

What Technology (Tech Stack) Is Used bySalix Pharmaceuticals?

Discover the tools Salix Pharmaceuticals uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Salix Pharmaceuticals Email Formats and Examples

Email addresses for employees at Salix Pharmaceuticals generally follow the conventions of its parent company, Bausch Health. The most common format is typically a combination of the employee's first and last name. Some Salix-specific roles or legacy communications might also utilize a @salix.com domain.

Common formats include [first].[last]@bauschhealth.com (e.g., john.doe@bauschhealth.com) or [f][last]@bauschhealth.com (e.g., jdoe@bauschhealth.com). Potentially, [first].[last]@salix.com (e.g., jane.doe@salix.com) may also be in use.

Format

robert.spurr@bauschhealth.com

Example

75%

Success rate

What's the Latest News About Salix Pharmaceuticals?

Bausch Health News Releases • February 22, 2024

Bausch Health Reports Strong Salix Segment Performance in Q4 and Full-Year 2023 Results

Bausch Health announced its fourth-quarter and full-year 2023 financial results, highlighting continued revenue growth in its Salix segment. Key products such as XIFAXAN® and TRULANCE® were noted as significant contributors to the segment's robust performance....more

Bausch Health News Releases • October 25, 2023

Salix Pharmaceuticals to Present New XIFAXAN® (Rifaximin) Data at the American College of Gastroenterology (ACG) 2023 Annual Scientific Meeting

Salix Pharmaceuticals announced it would present 17 scientific posters featuring new data on XIFAXAN® (rifaximin). The presentations covered its use for irritable bowel syndrome with diarrhea (IBS-D) and overt hepatic encephalopathy (OHE) at the ACG 2023 Annual Scientific Meeting....more

Bausch Health News Releases • May 4, 2023

Salix Showcases Commitment to Advancing GI Care with Data Presentations at Digestive Disease Week® (DDW) 2023

Salix Pharmaceuticals highlighted its ongoing dedication to the field of gastroenterology by presenting a wide range of data from its diverse GI portfolio at the Digestive Disease Week® (DDW) 2023 conference. The presentations included findings related to conditions such as IBS-D and HE....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Salix Pharmaceuticals, are just a search away.